OpenURL Connection Search

Select item for more details and to access through your institution.

Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene.
Published in:
Gene Therapy, 2004, v. 11, n. 6, p. 522, doi. 10.1038/sj.gt.3302184
By:
- Frelin, L;
- Ahlén, G;
- Alheim, M;
- Weiland, O;
- Barnfield, C;
- Liljeström, P
Publication type:
Article
Restriction of Hepatitis C Virus Heterogeneity during Prolonged Interferon-a Therapy in Relation to Changes in Virus Load.
Published in:
Journal of Infectious Diseases, 1996, v. 173, n. 4, p. 992, doi. 10.1093/infdis/173.4.992
By:
- Yun, Z. B.;
- Odeberg, J.;
- Lundeberg, J.;
- Weiland, O.;
- Uhlen, M.;
- Sönnerborg, A.
Publication type:
Article
Analyses of locomotion, wing morphology, and microbiome in Drosophila nigrosparsa after recovery from antibiotics.
Published in:
MicrobiologyOpen, 2022, v. 11, n. 3, p. 1, doi. 10.1002/mbo3.1291
By:
- Weiland, Simon O.;
- Detcharoen, Matsapume;
- Schlick‐Steiner, Birgit C.;
- Steiner, Florian M.
Publication type:
Article
AN EPIDEMIC OUTBREAK OF HEPATITIS A AMONG HOMOSEXUAL MEN IN STOCKHOLM.
Published in:
American Journal of Epidemiology, 1982, v. 116, n. 4, p. 599, doi. 10.1093/oxfordjournals.aje.a113442
By:
- CHRISTENSON, B.;
- BROSTRÜM, CH.;
- BÜTTIGER, M.;
- HERMANSON, J.;
- WEILAND, O.;
- RYD, G.;
- BERG, J. V. R.;
- SJÜBLOM, R.
Publication type:
Article
Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone.
Published in:
Journal of Medical Virology, 1995, v. 46, n. 1, p. 43, doi. 10.1002/jmv.1890460110
By:
- Schvarcz, R.;
- Yun, Z. B.;
- Sönnerborg, A.;
- Weiland, O.
Publication type:
Article
Lymphocyte subsets and β<sup>2</sup>--microgloblin expression in chronic hepatitis C/non--A, non--B. Effects of interferon--alpha treatment.
Published in:
Clinical & Experimental Immunology, 1992, v. 87, n. 3, p. 340
By:
- Wejstål, R.;
- Norkrans, G.;
- Weiland, O.;
- Schvrcz, R.;
- Fuchs, D.;
- Wachter, H.;
- Fryden, A.;
- Glaumann, H.
Publication type:
Article
Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden.
Published in:
European Journal of Clinical Pharmacology, 2018, v. 74, n. 7, p. 971, doi. 10.1007/s00228-018-2456-y
By:
- Frisk, P.;
- Aggefors, K.;
- Cars, T.;
- Feltelius, N.;
- Loov, S. A.;
- Wettermark, B.;
- Weiland, O.
Publication type:
Article
Prevalence of Hepatitis B Virus Markers in Sweden: A Community-based Serosurvey of 4,000 Young Swedish Adults.
Published in:
American Journal of Epidemiology, 1992, v. 135, n. 4, p. 409, doi. 10.1093/oxfordjournals.aje.a116301
By:
- Struve, J.;
- Giesecke, J.;
- Olcen, P.;
- von Sydow, M.;
- Weiland, O.
Publication type:
Article
Cirrhosis, high age and high body mass index are risk factors for persisting advanced fibrosis after sustained virological response in chronic hepatitis C.
Published in:
Journal of Viral Hepatitis, 2018, v. 25, n. 7, p. 802, doi. 10.1111/jvh.12879
By:
- Hedenstierna, M.;
- Nangarhari, A.;
- El‐Sabini, A.;
- Weiland, O.;
- Aleman, S.
Publication type:
Article
Long-term follow-up of successful hepatitis C virus therapy: waning immune responses and disappearance of liver disease are consistent with cure.
Published in:
Alimentary Pharmacology & Therapeutics, 2015, v. 41, n. 6, p. 532, doi. 10.1111/apt.13096
By:
- Hedenstierna, M.;
- Weiland, O.;
- Brass, A.;
- Bankwitz, D.;
- Behrendt, P.;
- Uhnoo, I.;
- Aleman, S.;
- Cardell, K.;
- Fryden, A.;
- Norkrans, G.;
- Eilard, A.;
- Glaumann, H.;
- Pietschmann, T.;
- Sällberg, M.;
- Brenndörfer, E. D.
Publication type:
Article
Evolution of fibrosis during HCV recurrence after liver transplantation - influence of IL-28B SNP and response to peg- IFN and ribavirin treatment.
Published in:
Journal of Viral Hepatitis, 2013, v. 20, n. 11, p. 770, doi. 10.1111/jvh.12099
By:
- Ackefors, M.;
- Nyström, J.;
- Wernerson, A.;
- Gjertsen, H.;
- Sönnerborg, A.;
- Weiland, O.
Publication type:
Article
Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirin.
Published in:
Journal of Viral Hepatitis, 2013, v. 20, n. 4, p. e82, doi. 10.1111/jvh.12014
By:
- Lindh, M.;
- Arnholm, B.;
- Björkman, P.;
- Hellstrand, K.;
- Lagging, M.;
- Nilsson, S.;
- Wahlberg, T.;
- Wallmark, E.;
- Weiland, O.;
- Wejstål, R.;
- Westin, J.;
- Widell, A.;
- Norkrans, G.
Publication type:
Article
HCV RNA decline in chronic HCV genotype 2 and 3 during standard of care treatment according to IL28B polymorphism.
Published in:
Journal of Viral Hepatitis, 2013, v. 20, n. 3, p. 193, doi. 10.1111/j.1365-2893.2012.01645.x
By:
- Stenkvist, J.;
- Sönnerborg, A.;
- Weiland, O.
Publication type:
Article
Concentration-guided ribavirin dosing with darbepoetin support and peg-IFN alfa-2a for treatment of hepatitis C recurrence after liver transplantation.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 9, p. 635, doi. 10.1111/j.1365-2893.2012.01587.x
By:
- Ackefors, M.;
- Gjertsen, H.;
- Wernerson, A.;
- Weiland, O.
Publication type:
Article
Lower-than-standard dose peg-IFN alfa-2a for chronic hepatitis C caused by genotype 2 and 3 is sufficient when given in combination with weight-based ribavirin.
Published in:
Journal of Viral Hepatitis, 2008, v. 15, n. 9, p. 641, doi. 10.1111/j.1365-2893.2008.00999.x
By:
- Weiland, O.;
- Hollander, A.;
- Mattsson, L.;
- Glaumann, H.;
- Lindahl, K.;
- Schvarcz, R.;
- Lindh, G.;
- Enquist, R.;
- Quist, A.
Publication type:
Article
Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response.
Published in:
Journal of Viral Hepatitis, 2005, v. 12, n. 5, p. 473, doi. 10.1111/j.1365-2893.2005.00621.x
By:
- Carlsson, T.;
- Reichard, O.;
- Norkrans, G.;
- Bläckberg, J.;
- Sangfelt, P.;
- Wallmark, E.;
- Weiland, O.
Publication type:
Article

Found: 16